RNS Number : 5692A
Fevertree Drinks PLC
25 May 2023
 

 

25th May 2023

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Board Changes

Fever-Tree announces that Coline McConville has informed the Board of her intention to step down from the Board of the Company later this year, having served nine years as a Non-Executive Director.

 

Following the conclusion of today's AGM, Coline will be succeeded as Senior Independent Director by Kevin Havelock who joined the Board in January 2018. Laura Hagan, who joined the Board and the Remuneration Committee in May 2021, will take over from Coline as Chair of the Remuneration Committee.

 

Additionally, the Board is pleased to announce the appointment of Clare Swindell as an Independent Non-Executive Director and Chair of the Audit Committee following the conclusion of today's AGM.

 

Clare is a qualified Chartered Accountant and has extensive experience within the consumer brand sector. She is currently Co-CEO at Camelot, operator of The National Lottery, having joined as CFO in 2017 before being appointed to the board in 2019. Prior to that she was Group CFO at dunnhumby, having previously spent over 17 years at Tesco where she worked across a wide range of operational and financial positions, including CFO for Tesco.com and Group Audit Director.

 

Bill Ronald, Chairman, said: "I would like to thank Coline for her contribution to Fever-Tree over the last eight and half years as a Non-Executive Director. Her knowledge and experience have been invaluable throughout an important period of growth for the Company and I am delighted she is remaining on the Board for the coming months to ensure a smooth transition."

 

"On behalf of my Board colleagues and incoming Chair, Dom De Lorenzo, I would also like to welcome Clare to the Board. She brings with her significant financial and consumer sector expertise which I have no doubt will be of great value to the Board going forward."

 

Regulatory Disclosures

The following information regarding the appointment of Clare Lester-Swindell (known as Clare Swindell), aged 53, is disclosed under Rule 17 and Schedule 2(g) of the AIM Rules for Companies:   

Current directorships and/or partnerships:

Camelot UK Lotteries Limited

Former directorships and/or partnerships (within the last five years):

CISL Limited

Camelot Lotteries Limited

Wholesale Commercial Collections Ltd

National Lottery Enterprises Limited

Clare Swindell does not currently hold any shares in the Company.

There are no further disclosures to be made in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

Ends

 

For further information:

 

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)2045 168 106

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

 

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

 

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan I +44 (0)7826 534 233

 

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 85 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFLDEEISFIV